© The Financial Times Ltd 2015 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Jul 03, 2015, the consensus forecast amongst 2 polled investment analysts covering GW Pharmaceuticals plc advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Jun 25, 2015. The previous consensus forecast advised investors to hold their position in GW Pharmaceuticals plc.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The one analyst offering a 12 month price target expects GW Pharmaceuticals plc share price to fall to 530.00 in the next year from the last price of 652.00. View Full Financials
Dividend information is not available for GW Pharmaceuticals PLC. View Full Financials
On May 11, 2015, GW Pharmaceuticals plc reported 2nd quarter 2015 losses of -0.032 per share.
The next earnings announcement is expected on Aug 04, 2015. View Full Interim Financials
|Average growth rate||-78.29%|
GW Pharmaceuticals plc reported annual 2014 losses of -0.070 per share on Dec 02, 2014. View Full Annual Financials
|Average growth rate||-61.50%|
GW Pharmaceuticals plc had 2nd quarter 2015 revenues of 6.35m. The same period last year the company did not report revenues. View Full Interim Financials
|Average growth rate||-4.97%|
GW Pharmaceuticals plc had revenues for the full year 2014 of 30.05m. This was 10.08% above the prior year's results. View Full Annual Financials
|Average growth rate||+0.21%|